|
1
|
Fan YH, Xiao B, Lv SG, Ye MH, Zhu XG and
Wu MJ: Lentivirus-mediated knockdown of chondroitin polymerizing
factor inhibits glioma cell growth in vitro. Oncol Rep.
38:1149–1155. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xiao B, Fan Y, Ye M, Lv S, Xu B, Chai Y,
Wu M and Zhu X: Downregulation of COUP-TFII inhibits glioblastoma
growth via targeting MPC1. Oncol Lett. 15:9697–9702.
2018.PubMed/NCBI
|
|
3
|
Ji CX, Fan YH, Xu F, Lv SG, Ye MH, Wu MJ,
Zhu XG and Wu L: MicroRNA-375 inhibits glioma cell proliferation
and migration by downregulating RWDD3 in vitro. Oncol Rep.
39:1825–1834. 2018.PubMed/NCBI
|
|
4
|
Huang A, Ho CS, Ponzielli R,
Barsyte-Lovejoy D, Bouffet E, Picard D, Hawkins CE and Penn LZ:
Identification of a novel c-Myc protein interactor, JPO2, with
transforming activity in medulloblastoma cells. Cancer Res.
65:5607–5619. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schmidt EV: The role of c-myc in cellular
growth control. Oncogene. 18:2988–2996. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Oster SK, Ho CS, Soucie EL and Penn LZ:
The myc oncogene: Marvelously Complex. Adv Cancer Res. 84:81–154.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yi R, Feng J, Yang S, Huang X, Liao Y, Hu
Z and Luo M: miR-484/MAP2/c-Myc-positive regulatory loop in glioma
promotes tumor-initiating properties through ERK1/2 signaling. J
Mol Histol. 49:209–218. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tian Y, Huang C, Zhang H, Ni Q, Han S,
Wang D, Han Z and Li X: CDCA7L promotes hepatocellular carcinoma
progression by regulating the cell cycle. Int J Oncol.
43:2082–2090. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shen FZ, Li XS, Ma JW, Wang XY, Zhao SP,
Meng L, Liang SF and Zhao XL: Cell division cycle associated 7 like
predicts unfavorable prognosis and promotes invasion in glioma.
Pathol Res Pract. 215:50–56. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Prescott JE, Osthus RC, Lee LA, Lewis BC,
Shim H, Barrett JF, Guo Q, Hawkins AL, Griffin CA and Dang CV: A
novel c-Myc-responsive gene, JPO1, participates in neoplastic
transformation. J Biol Chem. 276:48276–48284. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Goto Y, Hayashi R, Muramatsu T, Ogawa H,
Eguchi I, Oshida Y, Ohtani K and Yoshida K: JPO1/CDCA7, a novel
transcription factor E2F1-induced protein, possesses intrinsic
transcriptional regulator activity. Biochim Biophys Acta.
1759:60–68. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ou XM, Chen K and Shih JC: Monoamine
oxidase A and repressor R1 are involved in apoptotic signaling
pathway. Proc Natl Acad Sci USA. 103:10923–10928. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li X, Tian Z, Jin H, Xu J, Hua X, Yan H,
Liufu H, Wang J, Li J, Zhu J, et al: Decreased c-Myc mRNA stability
via the MicroRNA 141-3p/AUF1 axis is crucial for p63alpha
inhibition of cyclin D1 gene transcription and bladder cancer cell
tumorigenicity. Mol Cell Biol. 38:2018. View Article : Google Scholar
|
|
15
|
Ma J, Ren Y, Zhang L, Kong X, Wang T, Shi
Y and Bu R: Knocking-down of CREPT prohibits the progression of
oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc
expression. PLoS One. 12:e01743092017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vadde R, Radhakrishnan S, Reddivari L and
Vanamala JK: Triphala extract suppresses proliferation and induces
apoptosis in human colon cancer stem cells via suppressing
c-Myc/Cyclin D1 and elevation of Bax/Bcl-2 ratio. Biomed Res Int.
2015:6492632015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu Z, Zeng X, Tian D, Xu H, Cai Q, Wang J
and Chen Q: MicroRNA-383 inhibits anchorage-independent growth and
induces cell cycle arrest of glioma cells by targeting CCND1.
Biochem Biophys Res Commun. 453:833–838. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim MK, Park GH, Eo HJ, Song HM, Lee JW,
Kwon MJ, Koo JS and Jeong JB: Tanshinone I induces cyclin D1
proteasomal degradation in an ERK1/2 dependent way in human
colorectal cancer cells. Fitoterapia. 101:162–168. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xia B, Yang S, Liu T and Lou G: miR-211
suppresses epithelial ovarian cancer proliferation and cell-cycle
progression by targeting Cyclin D1 and CDK6. Mol Cancer. 14:572015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Monteiro LS, Diniz-Freitas M,
Warnakulasuriya S, Garcia- Caballero T, Forteza-Vila J and Fraga M:
Prognostic significance of cyclins A2, B1, D1, and E1 and CCND1
numerical aberrations in oral squamous cell carcinomas. Anal Cell
Pathol (Amst). 2018:72535102018.PubMed/NCBI
|
|
21
|
Katunaric M, Jurisic D, Petkovic M,
Grahovac M, Grahovac B and Zamolo G: EGFR and cyclin D1 in nodular
melanoma: Correlation with pathohistological parameters and overall
survival. Melanoma Res. 24:584–591. 2014. View Article : Google Scholar : PubMed/NCBI
|
